The cycloadducts formed from the Diels−Alder reaction
of 3-amino-5-chloro-2(1H)-pyrazinones with
methyl acrylate in toluene are subject to two alternative modes of ring
transformation yielding
either methyl 6-cyano-1,2-dihydro-2-oxo-4-pyridinecarboxylates, e.g.
12a,b (loss of amine substituent), or the corresponding
3-amino-6-cyano-1,2,5,6-tetrahydro-2-oxo-4-pyridinecarboxylates,
e.g.
15a,b. From the latter compounds, 3-amino-2-pyridinones
can be generated through subsequent
loss of HCN. A mechanism accounting for the loss or retention of
the amine substituent is based
on (1) the effects observed for each reaction mode when varying the
substituents in both reaction
partners and (2) the exclusive retention of the amine substituent when
replacing toluene with the
basic solvent pyridine.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
RingTransformations of 3-(Diethylamino)-5-chloro-2(1H)pyrazinones and the Corresponding 2H-1,4-Oxazin-2-ones on Reaction with Acetylenic Compounds.-The pyrazinones (IIa) -(IIc) and (IV) or the 1,4-oxazinones (IId) and (IIe) react with the acetylenes (I) to undergo a cycloaddition process, followed by cleavage and rearrangement, forming the pyridinones (IIIa) -(IIIc) and (V) and the pyranones (IIId) and (IIIe). (Mechanism). -(TUTONDA, M. G.; VANDENBERGHE, S. M.; VAN AKEN, K. J.; HOORNAERT, G.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.